Drug Profile
Progesterone conjugate - Levolta Pharmaceuticals
Alternative Names: VOLT-02Latest Information Update: 25 Dec 2021
Price :
$50
*
At a glance
- Originator Levolta Pharmaceuticals
- Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Brain injuries; Female genital diseases; Menstruation disorders
Most Recent Events
- 24 Mar 2017 Phase-II development for Brain injuries, Gynaecological disorders, and Menstruation disorders is ongoing in USA
- 03 Nov 2014 Phase-II clinical trials in Brain injuries in USA (Parenteral)
- 03 Nov 2014 Phase-II clinical trials in Gynaecological disorders in USA (unspecified route)